Table 1.

Summary of Primary Outcomes

Comparison GroupADL DisabilityInstrumental ADL DisabilityMobility Disability
First author, Publication YearStatistical Measure (95% CI)First Author, Publication YearStatistical measure (95% CI)First Author, Publication YearStatistical Measure (95% CI)
Frailty without cognitive impairment (physical frailty) versus robustAvila-Funes (2009)OR 2.50 (1.14–5.49)Avila-Funes (2009)OR 2.30 (1.49–3.55)Avila-Funes (2009)OR 1.32 (0.70–2.52)
Chen (2020)OR 2.31 (1.53–3.48)Chen (2020)OR 2.23 (1.43–3.47)Chen (2020)OR 1.29 (0.52–3.18)
Ma (2021)OR 5.47 (2.03–14.75)
Aliberti (2019)sHR 1.70 (1.40–2.00)
Frailty with cognitive impairment (cognitive frailty) versus robustAvila-Funes (2009)OR 5.60 (2.13–14.70)Avila-Funes (2009)OR 3.17 (1.47–6.83)Avila-Funes (2009)OR 3.88 (0.78–19.41)
Chen (2020)OR 2.22 (0.97–5.08)Chen (2020)OR 2.80 (1.00–7.87)Chen (2020)OR 1.00
Ma (2021)OR 10.48 (2.98–36.80)Shimada (2016)OR 2.63 (1.74–3.97)Liu (2018)aRR 3.10 (2.60–3.60)
Aliberti (2019)sHR 2.00 (1.60–2.60)Liu (2018)aRR 2.30 (2.10–2.60)
Liu (2018)aRR 20.60 (15.70–26.90)
Prefrailty without cognitive impairment versus robustAvila-Funes (2009)OR 0.72 (0.38–1.36)Avila-Funes (2009)OR 1.49 (1.17–1.89)Avila-Funes (2009)OR 1.34 (1.13–1.59)
Ma (2021)OR 2.34 (1.18–4.63)
Prefrailty with cognitive impairment versus robustAvila-Funes (2009)OR 1.17 (0.45–3.04)Avila-Funes (2009)OR 2.83 (1.91–4.19)Avila-Funes (2009)OR 1.15 (0.76–1.73)
Ma (2021)OR 3.28 (1.31–8.23)
Comparison GroupADL DisabilityInstrumental ADL DisabilityMobility Disability
First author, Publication YearStatistical Measure (95% CI)First Author, Publication YearStatistical measure (95% CI)First Author, Publication YearStatistical Measure (95% CI)
Frailty without cognitive impairment (physical frailty) versus robustAvila-Funes (2009)OR 2.50 (1.14–5.49)Avila-Funes (2009)OR 2.30 (1.49–3.55)Avila-Funes (2009)OR 1.32 (0.70–2.52)
Chen (2020)OR 2.31 (1.53–3.48)Chen (2020)OR 2.23 (1.43–3.47)Chen (2020)OR 1.29 (0.52–3.18)
Ma (2021)OR 5.47 (2.03–14.75)
Aliberti (2019)sHR 1.70 (1.40–2.00)
Frailty with cognitive impairment (cognitive frailty) versus robustAvila-Funes (2009)OR 5.60 (2.13–14.70)Avila-Funes (2009)OR 3.17 (1.47–6.83)Avila-Funes (2009)OR 3.88 (0.78–19.41)
Chen (2020)OR 2.22 (0.97–5.08)Chen (2020)OR 2.80 (1.00–7.87)Chen (2020)OR 1.00
Ma (2021)OR 10.48 (2.98–36.80)Shimada (2016)OR 2.63 (1.74–3.97)Liu (2018)aRR 3.10 (2.60–3.60)
Aliberti (2019)sHR 2.00 (1.60–2.60)Liu (2018)aRR 2.30 (2.10–2.60)
Liu (2018)aRR 20.60 (15.70–26.90)
Prefrailty without cognitive impairment versus robustAvila-Funes (2009)OR 0.72 (0.38–1.36)Avila-Funes (2009)OR 1.49 (1.17–1.89)Avila-Funes (2009)OR 1.34 (1.13–1.59)
Ma (2021)OR 2.34 (1.18–4.63)
Prefrailty with cognitive impairment versus robustAvila-Funes (2009)OR 1.17 (0.45–3.04)Avila-Funes (2009)OR 2.83 (1.91–4.19)Avila-Funes (2009)OR 1.15 (0.76–1.73)
Ma (2021)OR 3.28 (1.31–8.23)

Notes: ADL = activities of daily living; aRR = adjusted rate ratio; OR = odds ratio; sHR = sub-hazard ratio.

Table 1.

Summary of Primary Outcomes

Comparison GroupADL DisabilityInstrumental ADL DisabilityMobility Disability
First author, Publication YearStatistical Measure (95% CI)First Author, Publication YearStatistical measure (95% CI)First Author, Publication YearStatistical Measure (95% CI)
Frailty without cognitive impairment (physical frailty) versus robustAvila-Funes (2009)OR 2.50 (1.14–5.49)Avila-Funes (2009)OR 2.30 (1.49–3.55)Avila-Funes (2009)OR 1.32 (0.70–2.52)
Chen (2020)OR 2.31 (1.53–3.48)Chen (2020)OR 2.23 (1.43–3.47)Chen (2020)OR 1.29 (0.52–3.18)
Ma (2021)OR 5.47 (2.03–14.75)
Aliberti (2019)sHR 1.70 (1.40–2.00)
Frailty with cognitive impairment (cognitive frailty) versus robustAvila-Funes (2009)OR 5.60 (2.13–14.70)Avila-Funes (2009)OR 3.17 (1.47–6.83)Avila-Funes (2009)OR 3.88 (0.78–19.41)
Chen (2020)OR 2.22 (0.97–5.08)Chen (2020)OR 2.80 (1.00–7.87)Chen (2020)OR 1.00
Ma (2021)OR 10.48 (2.98–36.80)Shimada (2016)OR 2.63 (1.74–3.97)Liu (2018)aRR 3.10 (2.60–3.60)
Aliberti (2019)sHR 2.00 (1.60–2.60)Liu (2018)aRR 2.30 (2.10–2.60)
Liu (2018)aRR 20.60 (15.70–26.90)
Prefrailty without cognitive impairment versus robustAvila-Funes (2009)OR 0.72 (0.38–1.36)Avila-Funes (2009)OR 1.49 (1.17–1.89)Avila-Funes (2009)OR 1.34 (1.13–1.59)
Ma (2021)OR 2.34 (1.18–4.63)
Prefrailty with cognitive impairment versus robustAvila-Funes (2009)OR 1.17 (0.45–3.04)Avila-Funes (2009)OR 2.83 (1.91–4.19)Avila-Funes (2009)OR 1.15 (0.76–1.73)
Ma (2021)OR 3.28 (1.31–8.23)
Comparison GroupADL DisabilityInstrumental ADL DisabilityMobility Disability
First author, Publication YearStatistical Measure (95% CI)First Author, Publication YearStatistical measure (95% CI)First Author, Publication YearStatistical Measure (95% CI)
Frailty without cognitive impairment (physical frailty) versus robustAvila-Funes (2009)OR 2.50 (1.14–5.49)Avila-Funes (2009)OR 2.30 (1.49–3.55)Avila-Funes (2009)OR 1.32 (0.70–2.52)
Chen (2020)OR 2.31 (1.53–3.48)Chen (2020)OR 2.23 (1.43–3.47)Chen (2020)OR 1.29 (0.52–3.18)
Ma (2021)OR 5.47 (2.03–14.75)
Aliberti (2019)sHR 1.70 (1.40–2.00)
Frailty with cognitive impairment (cognitive frailty) versus robustAvila-Funes (2009)OR 5.60 (2.13–14.70)Avila-Funes (2009)OR 3.17 (1.47–6.83)Avila-Funes (2009)OR 3.88 (0.78–19.41)
Chen (2020)OR 2.22 (0.97–5.08)Chen (2020)OR 2.80 (1.00–7.87)Chen (2020)OR 1.00
Ma (2021)OR 10.48 (2.98–36.80)Shimada (2016)OR 2.63 (1.74–3.97)Liu (2018)aRR 3.10 (2.60–3.60)
Aliberti (2019)sHR 2.00 (1.60–2.60)Liu (2018)aRR 2.30 (2.10–2.60)
Liu (2018)aRR 20.60 (15.70–26.90)
Prefrailty without cognitive impairment versus robustAvila-Funes (2009)OR 0.72 (0.38–1.36)Avila-Funes (2009)OR 1.49 (1.17–1.89)Avila-Funes (2009)OR 1.34 (1.13–1.59)
Ma (2021)OR 2.34 (1.18–4.63)
Prefrailty with cognitive impairment versus robustAvila-Funes (2009)OR 1.17 (0.45–3.04)Avila-Funes (2009)OR 2.83 (1.91–4.19)Avila-Funes (2009)OR 1.15 (0.76–1.73)
Ma (2021)OR 3.28 (1.31–8.23)

Notes: ADL = activities of daily living; aRR = adjusted rate ratio; OR = odds ratio; sHR = sub-hazard ratio.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close